Post by
Noteable on Sep 19, 2023 12:06pm
Novartis returns anti-PD1 to Chinese based company BeiGene
https://www.biospace.com/article/releases/beigene-strengthens-global-portfolio-and-regains-full-rights-from-novartis-for-anti-pd-1-antibody-tevimbra-tislelizumab-/
Comment by
Noteable on Sep 19, 2023 5:13pm
https://www.cantor.com/our-company/conferences/global-healthcare-conference-2023/
Comment by
Noteable on Sep 19, 2023 8:36pm
In case anyone missed this ... [ ONCYs Bracelet-1 study demonstrated that a non-silenced Fc receptor site on a PD-1 checkpoint inhibitor like avelumab (Bavencio) for example, resulted in significantly reduced efficacy of that PD-1 checkpoint inhibitor. avelumab has a native Fc region that retains FcγR binding capability as does tislelizumab] -- https://pubmed.ncbi.nlm.nih.gov/34484871/
Comment by
13X2413 on Sep 20, 2023 9:16am
Can't they come up with something better than a fireside chat? Opening doesn't look promising.
Comment by
Lesalpes29 on Sep 20, 2023 9:23am
13x... you said not a long timo ago that you sold... Thank you to continue to post here to help the real longs here to understand the science! Euh... You can write to PanCan people too, they are lost like us! GLTAL
Comment by
13X2413 on Sep 20, 2023 9:28am
You think I'd be posting here if I sold. Still long, that's why I'm p*ssed. Still hoping for a miracle.
Comment by
Lesalpes29 on Sep 20, 2023 10:26am
OK, smile it will be a green day... probably!